Senior executive with more than 25 years of international experience in the areas of animal and human pharmaceutical industries in mostly general and regional management roles. Successful and sustainable P&L track record in building and growing complex multinational organizations covering up to 730 M$ in revenue and up to 850 employees. Proven expertise in strategic and operational leadership, business turnaround, sales & marketing operations and integration of acquired companies. Blend of senior leadership skills out of line-management and cross functional matrix capabilities. Specific experience in commercial integration planning and execution, as well as commercial excellence in B2B and B2C markets with direct impact on people, financials and processes from global to local levels. Customer and results focused with a passion for winning as a team. Inspired, inclusive leader recognized for creating and building high performing, engaged teams thriving in challenging and transformational business situations. Disciplined, determined and analytical approach to work with resilience on delivering against set targets with a passion for people. Leadership and governance experience as President and Board Director of multiple companies and industry associations. Worked and lived in Germany, Switzerland, Australia and Malaysia - employed by multinational pharmaceutical companies including Elanco/Eli Lilly, Novartis, Boehringer Ingelheim and Pfizer.